3E Bioventures Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
45
- Portfolio
-
29
- Exits
-
13
3E Bioventures Capital General Information
Company Description
Founded in 2015, 3E Bioventures Capital is a venture capital firm based in Palo Alto, California. The firm prefers to invest in companies operating in the life sciences, health innovators, biotech (new drugs, new modalities, and drug discovery platforms), tech bio and biomedical technology sectors.
Business Details
Website
www.3ebiovc.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 228 Hamilton Avenue
- 3rd Floor
- Palo Alto, CA 94301
- United States
3E Bioventures Capital Investments (45)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Myrobalan Therapeutics | 10-Jan-2024 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| KingAgroot | 08-Aug-2023 | Agricultural Chemicals | Generating Revenue | |||
| Larkspur Biosciences | 23-May-2023 | Drug Delivery | Generating Revenue | |||
| Xunyuan Technology | 27-Apr-2023 | Environmental Services (B2B) | Startup | |||
| Smartlens | 17-Apr-2023 | Monitoring Equipment | Clinical Trials - General | |||
| Jingjie Bio | 24-Feb-2023 | Diagnostic Equipment | Generating Revenue | |||
| Eluminex Biosciences | 14-Feb-2023 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Xiaoying AI | 07-Feb-2023 | Biotechnology | Generating Revenue | |||
| Retex Pharmaceuticals | 01-Feb-2023 | Early Stage VC | Drug Discovery | Startup | ||
| Junhemeng | 16-Jan-2023 | Early Stage VC | Drug Delivery | Generating Revenue |
3E Bioventures Capital Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Refuge Biotech | 03-Aug-2023 | Out of Business | |
| Cardea | 29-Apr-2023 | ||
| Bayland Scientific | 20-Dec-2021 | ||
| Cognition Therapeutics | 08-Oct-2021 | ||
| Eucure Biopharma | 24-Sep-2020 | ||
| Reach Surgical | 01-Jan-2019 | ||
| Rainbow Children's Clinic | 22-Sep-2018 | ||
| BioChain Institute | 06-Jul-2016 | ||
| BGI Tech | 14-Jan-2015 | Merger of Equals | |
| Cytoville | Secondary Transaction - Private |
3E Bioventures Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
3E Bioventures Capital Co-Investors (91)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Foothill Ventures | 2 |
|
|
||
| GL Ventures |
|
|
|||
| Polaris Partners |
|
|
|||
| General Catalyst |
|
|
|||
| Wilson Sonsini Goodrich & Rosati |
|
|
3E Bioventures Capital FAQs
-
What is 3E Bioventures Capital?
Founded in 2015, 3E Bioventures Capital is a venture capital firm based in Palo Alto, California.
-
When was 3E Bioventures Capital founded?
3E Bioventures Capital was founded in 2015.
-
Where is 3E Bioventures Capital headquartered?
3E Bioventures Capital is headquartered in Palo Alto, CA.
-
How many investments has 3E Bioventures Capital made?
3E Bioventures Capital has made 45 investments.
-
What has 3E Bioventures Capital invested in?
3E Bioventures Capital has made numerous investments in companies like Myrobalan Therapeutics, KingAgroot, and Larkspur Biosciences within the Drug Discovery, Agricultural Chemicals, and Drug Delivery industries.
-
What has 3E Bioventures Capital invested in recently?
3E Bioventures Capital's latest investment was on 10-Jan-2024 in Myrobalan Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
